Literature DB >> 27785884

Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension.

Roland E Schmieder1, Agnes Jumar1, Eva-Maria Fronk2, Ana-Filipa Alexandre2, Peter Bramlage3.   

Abstract

Often considered to be a symptomless condition, hypertension can be associated with a significant emotional burden. To analyze changes of health-related quality of life as well as the emotional burden questions regarding the impact of hypertension were incorporated into the noninterventional SeviTarget study. Comparisons were made between baseline and follow-up findings, and between patients with treatment target achievement and those without. A total of 5831 patients were recruited. At baseline, only 33.3% of patients described their current state of health as good or excellent, while at follow-up this value had risen to 75.8%. Responses regarding symptoms and limitations in activities and mental factors such as anxiety associated with treatment all improved during antihypertensive treatment. Changes to more optimistic responses were more likely for patients who achieved a target BP of <140/90 mm Hg. The study demonstrates that improvements in quality of life and the perceived emotional burden related to hypertension can be achieved with effective management of hypertension. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  blood pressure control; fixed-dose combination therapy; hypertension; mental health; quality of life

Mesh:

Substances:

Year:  2016        PMID: 27785884      PMCID: PMC8031145          DOI: 10.1111/jch.12936

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care.

Authors:  Peter Bramlage; Wolf-Peter Wolf; Eva-Maria Fronk; Thomas Stuhr; Wolfhard Erdlenbruch; Jürgen Wasem; Reinhard Ketelhut; Roland E Schmieder
Journal:  Expert Opin Pharmacother       Date:  2010-10-08       Impact factor: 3.889

2.  Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.

Authors:  Eni C Okonofua; Kit N Simpson; Ammar Jesri; Shakaib U Rehman; Valerie L Durkalski; Brent M Egan
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

3.  Associations between subjective social status and physical and mental health functioning among patients with hypertension.

Authors:  Crystal W Cené; Jacqueline R Halladay; Ziya Gizlice; Kyle Roedersheimer; Alan Hinderliter; Doyle M Cummings; Katrina E Donahue; Andrew J Perrin; Darren A DeWalt
Journal:  J Health Psychol       Date:  2016-07-10

4.  Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.

Authors:  Gavin W Lambert; Dagmara Hering; Murray D Esler; Petra Marusic; Elisabeth A Lambert; Stephanie K Tanamas; Jonathan Shaw; Henry Krum; John B Dixon; David A Barton; Markus P Schlaich
Journal:  Hypertension       Date:  2012-10-15       Impact factor: 10.190

5.  Replicability of SF-36 summary scores by the SF-12 in stroke patients.

Authors:  A S Pickard; J A Johnson; A Penn; F Lau; T Noseworthy
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

6.  Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countries.

Authors:  Peter Bramlage; Martin Thoenes; Wilhelm Kirch; Claude Lenfant
Journal:  Curr Med Res Opin       Date:  2007-04       Impact factor: 2.580

7.  Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study.

Authors:  Roland E Schmieder; Guido Grassi; Sverre E Kjeldsen
Journal:  J Hypertens       Date:  2013-03       Impact factor: 4.844

Review 8.  Hypertension 2008--awareness, understanding, and treatment of previously diagnosed hypertension in baby boomers and seniors: a survey conducted by Harris interactive on behalf of the Preventive Cardiovascular Nurses Association.

Authors:  Nancy H Miller; Kathy Berra; Janet Long
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

9.  Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension.

Authors:  Roland E Schmieder; Agnes Jumar; Eva-Maria Fronk; Ana-Filipa Alexandre; Peter Bramlage
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-27       Impact factor: 3.738

10.  Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension.

Authors:  Pedro Marques da Silva; Uwe Haag; Julian F Guest; John E Brazier; Marco Soro
Journal:  Health Qual Life Outcomes       Date:  2015-02-21       Impact factor: 3.186

View more
  3 in total

1.  Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension.

Authors:  Roland E Schmieder; Agnes Jumar; Eva-Maria Fronk; Ana-Filipa Alexandre; Peter Bramlage
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-27       Impact factor: 3.738

2.  Improved quality of life and nonspecific symptoms with fixed-dose combination drugs.

Authors:  Samuel O Schumann
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-27       Impact factor: 3.738

3.  ARE THERE RELIABLE PREDICTORS FOR THE IMPAIRED QUALITY OF LIFE IN PATIENTS WITH CUSHING'S SYNDROME?

Authors:  A B Nankova; M Yaneva; A Elenkova; K Kalinov; S Zacharieva
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.